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Donald Frederick Steiner, MD, a scientist whose research fun-
damentally changed our view of insulin production, died from
natural causes at his home in Chicago on Tuesday, 11 Novem-
ber 2014. He was 84 years old, and had been a member of the
University of Chicago faculty since 1960.
Steiner, the A.N. Pritzker Distinguished Service Professor
Emeritus in the Departments of Medicine and Biochemistry &
Molecular Biology at the University of Chicago, revolutionised
thinking about insulin synthesis and secretion. In 1967, he
showed that insulin, thought to be made from two separate pro-
tein chains, was derived from a single chain precursor, which he
named ‘proinsulin’. Steiner showed how a small interior part of
that single long chain was removed by proteolytic processing
leaving behind two chains (A and B) connected by disulphide
bonds, which together comprise the insulin molecule. The
interior segment that was removed was termed ‘C-peptide’ for
‘connecting peptide’.
Like so many breakthroughs, the discovery of proinsulin
began with a preparedmind and a stroke of luck. In September
1965, Steiner learned that a gastrointestinal surgeon at the
University of Chicago was about to perform a resection on a
patient with an insulinoma. Steiner called to request a sample
and the surgeon agreed.
‘When I got the tumor tissue,’ Steiner later recalled, ‘I
decided to see what I could find out.’ He froze the tissue for
6 weeks while he read up on various methods of working with
pancreatic tissue [1].
He started his experiments on 24 October 1965 and soon
found that, in addition to insulin, the cells also produced a
larger protein related chemically and immunologically to in-
sulin. When he exposed the larger protein to the enzyme tryp-
sin, it was converted to a protein that was indistinguishable
from insulin. These findings were published in a paper in
Proceedings of the National Academy of Sciences in February
K. S. Polonsky (*)
Department of Medicine, University of Chicago, 5841 S Maryland
Ave, Chicago, IL 60637, USA
e-mail: polonsky@bsd.uchicago.edu
A. H. Rubenstein
Department of Medicine, Raymond and Ruth Perelman School of
Medicine, University of Pennysylvania, Philadelphia, PA, USA
Diabetologia (2015) 58:419–421
DOI 10.1007/s00125-015-3495-x
1967 [2]. Subsequently Steiner discovered a larger precursor
that he called ‘preproinsulin’. In 1968, a team of scientists at
Eli Lilly, although initially sceptical, confirmed the finding.
Within 10 years, Steiner and others found that this mechanism
of proteolytic processing of a large single chain precursor to
form the smaller mature peptide applied to many other hor-
mones and neuropeptides. Steiner’s discovery was therefore
broadly applicable throughout biology.
This fundamental discovery paved the way to understand-
ing how other hormones, such as glucagon, as well as neuro-
peptides in the brain and endocrine system, are made and
processed, thus establishing the field of protein-precursor pro-
cessing. It enabled the pharmaceutical industry to improve the
purity of insulin preparations, leading to insulins that were less
likely to provoke an immune response, and paved the way for
biosynthetic human insulin production.
This was, by anyone’s standards, a remarkable piece of
work—a truly creative and ultimately beautiful set of experi-
ments. No one else at that time, his colleagues insist, was
thinking through such problems in the same way. Steiner’s
careful and imaginative work has impacted on millions of
people who have been treated with insulin.
Steiner gave generously of his time and expertise to col-
leagues, collaborators and trainees. It was well known that
when junior colleagues went to seek advice about a scientific
problem they would have the benefit of his complete attention
and the breadth of his knowledge and experience. Steiner
loved to talk about science and to think about how to solve
scientific problems in creative ways.
Dr Rudolph Leibel, a director of the Naomi Berrie Diabetes
Center at Columbia University College of Physicians and Sur-
geons, told the New York Times that the discovery of proin-
sulin ‘opened a window into a whole area of molecular phys-
iology that people were not aware of.’ Despite his fundamen-
tal discoveries, he added, Dr Steiner ‘was very modest, and
very concerned about young people—his students and his co-
workers. He’s from that era, these great thinkers who were
soft-spoken and gentlemanly and not in it for anything but
the joy of doing the science. We don’t have as much of that
now’ [3].
The discovery of proinsulin has also had substantial impli-
cations for understanding the physiology of insulin secretion
and for clinical medicine. Thus measurement of C-peptide in
the bloodstream provides a very accurate indication of how
much insulin is produced by the body, and this has been exten-
sively used as an independent indicator of insulin secretion in
clinical studies and in clinical trials. Circulating proinsulin has
also been used for the diagnosis of insulin-secreting tumours of
the pancreas and has also been shown to be an early marker of
pancreatic beta cell dysfunction in the evolution of diabetes.
In 1983, 16 years after his ground-breaking paper on pro-
insulin, Steiner was part of a University of Chicago team that
described the first mutations in the insulin gene, now known
as ‘insulin Chicago’ [4]. Such mutations—we now know
more than 30—are associated with syndromes that combine
mild diabetes and elevated circulating insulin or proinsulin.
Other mutations in the insulin gene have been associated with
neonatal diabetes. Steiner also contributed to work on under-
standing how insulin binds to its receptor and on insulin re-
ceptor mutations.
Donald F. Steiner was born in Lima, Ohio, on 15 July 1930.
Colleagues said his small-town roots shaped his personality.
He grew up in a family with a strong belief in honesty, gener-
osity and hard work, with respect for everyone. That, together
with his scientific brilliance, made him the perfect mentor. He
taught the people he trained how to do research and then gave
them the credit for doing what he taught them. That’s one
reason so many good people flocked to his lab, where he only
made them better.
Steiner earned his BS in chemistry and zoology from the
University of Cincinnati in 1952, followed by an MS in bio-
chemistry and anMD from the University of Chicago in 1956.
He completed his internship at King County Hospital in
Seattle, followed by a residency and post-doctoral fellowship
at the University ofWashington. He was invited to return to the
University of Chicago as an assistant professor of biochemistry
in 1960.
He rose quickly through the ranks, becoming a full profes-
sor in 1968 and department chairman in 1973. From 1985 to
2006 he was a senior investigator in the Howard Hughes
Medical Institute at the University of Chicago. He also served
as director of the University of Chicago Diabetes and Endo-
crinology Center (1974–1978), as well as associate director
(1977–1981), director (2000–2004) and co-director (2004–
2014) of the University of Chicago Diabetes Research and
Training Center. In those roles, he realised: ‘I could
get along with anyone… but basically, I am not interested in
administration’ [1].
He preferred to use his talents planning and performing
research, and teaching, and that paid off. Steiner published
more than 450 peer-reviewed papers. His work has been cited
more than 10,000 times by other researchers. He won dozens
of prestigious national and international honours and awards,
often several per year. These include the Lilly Award and the
BantingMedal for Scientific Achievement from the American
Diabetes Association, the JoslinMedal from the New England
Diabetes Association, Israel’s Wolf Prize [5] and, from Japan,
the Manpei Suzuki International Prize for Diabetes Research
[6]—the largest financial award for diabetes research. When
granting him the Borden Award, the Association of American
Medical Colleges said his ‘discovery of proinsulin is widely
regarded as one of the most exciting basic science discoveries
in the past two decades’ [7].
He was elected to membership of the American Academy
of Arts & Sciences in 1972, the National Academy of
Sciences in 1973, honorary membership of the European
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Association for the Study of Diabetes in 2001, and the
American Philosophical Society, the USA’s oldest learned
society, in 2004.
In addition to his seminal contributions to science, Don
Steiner has had a profound influence at the University of
Chicago, particularly on the diabetes programme. The broad
implications of his discoveries of the pathways of insulin bio-
synthesis and secretion placed the University of Chicago at the
forefront of diabetes research. In 2014, in appreciation of all
he had done for the institution, Dr Steiner was awarded the
University of Chicago Alumni Medal [8].
Steiner also was an avid patron of the arts, especially the
Chicago Symphony Orchestra. He helped support large and
small theatre companies and the opera. He was a talented
pianist. He played classical music on his Steinway grand pia-
no—an acquisition made possible by the Wolf Prize—in his
high-rise apartment overlooking Lake Michigan. In the late
1960s, while picking apart proinsulin, he meticulously assem-
bled a harpsichord in his basement laboratory at the University.
He also enjoyed sailing on Lake Michigan and gardening.
Because of Donald Steiner, we all know a lot more about
diabetes, and people with diabetes live better lives. The au-
thors of this remembrance came to the University of Chicago
to work with him. He was an extraordinary mentor for us and
for many people, combining professional brilliance with the
drive to solve hard problems and the capacity, once the job
was done, to share the credit. He was a model of how science
should be done and how a friend should behave.
The atmosphere in his laboratory was pleasant, but the
planning, execution and evaluation of experiments was rigor-
ous and meticulous. He spent hours worrying about unexpect-
ed results and repeated experiments numerous times before
being satisfied. We all felt part of his team and when new
discoveries were made, we all shared in the joy of the science
and celebrated together. Remarkably, he never spoke nega-
tively of others, even when they were critical or sceptical of
his work; rather, he was generous in his praise. This was
admired and respected by colleagues all over the world.
Despite his awards and accomplishments, Steiner was an
extraordinarily kind, humble, gentle and attentive person. He
always had time for his staff and colleagues, would answer
questions at length and in depth, and was absolutely devoted
to this University. We shall miss him profoundly.
Don Steiner is survived by Ellen Steiner, the wife of his late
brother Phares, by his niece Adrienne Steiner, his nephew
Paul Steiner, several cousins and many, many friends.
A memorial service is scheduled for 1 May 2015 at the
University of Chicago.
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